Kyntrabio
kyntrabio.com
Health Care
Rare Disease Therapeutics
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Foresite Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
SynaptixBio is a rare disease biotech pioneering ground-breaking development for treatment of severe leukodystrophies which affect the…
Eton is an innovative pharmaceutical company that searches the world over for meaningful therapies that we can bring to patients living…
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been…
Sidewinder Therapeutics is pioneering the next generation of large molecule precision therapeutics. We aim to deliver new life-saving…
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Foresite CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
Kyntra Bio, Inc. Headquarters
350 Bay St, Ste 100 #6009,, San Francisco, CA 94133 USA